Your browser doesn't support javascript.
loading
Bone disease in hypoparathyroidism.
Clarke, Bart L.
Afiliação
  • Clarke BL; Department of Internal Medicine, Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic College of Medicine, Rochester, Minnesota, United States.
Arq Bras Endocrinol Metabol ; 58(5): 545-52, 2014 Jul.
Article em En | MEDLINE | ID: mdl-25166046
Hypoparathyroidism is a rare disorder that may be acquired or inherited. Postsurgical hypoparathyroidism is responsible for the majority of acquired hypoparathyroidism. Bone disease occurs in hypoparathyroidism due to markedly reduced bone remodeling due to the absence or low levels of parathyroid hormone. Chronically reduced bone turnover in patients with hypoparathyroidism typically leads to higher bone mass than in age- and sex-matched controls. Whether this increased bone density reduces fracture risk is less certain, because while increased bone mineralization may be associated with increased brittleness of bone, this does not appear to be the case in hypoparathyroidism. Treatment of hypoparathyroidism with recombinant parathyroid hormone may reduce bone mineral density but simultaneously strengthen the mechanical properties of bone.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hormônio Paratireóideo / Doenças Ósseas / Hipoparatireoidismo Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Arq Bras Endocrinol Metabol Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hormônio Paratireóideo / Doenças Ósseas / Hipoparatireoidismo Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Arq Bras Endocrinol Metabol Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Brasil